MosaeQ (Mosae Zorg Industries) is pioneering the future of quantum computing for biodefense and materials research through our revolutionary cislunar infrastructure. Founded by F. Hanna Campbell, M.E., B.E., we deliver unprecedented predictive power for pathogen forecasting and protein computation.
Accelerating pharmaceutical development through quantum-enhanced preclinical analysis while maintaining complete algorithm transparency and user data ownership.
We provide unprecedented computational power for solving humanity's most pressing biological and materials challenges through quantum computing positioned at the Earth-Moon L1 Lagrange point. We unlock the 95% of missing pathogen data that classical AI cannot predict, enabling proactive threat detection and breakthrough drug development.
Exclusive access to real-time global methane concentration data for environmental stress correlation in drug stability predictions
Full compliance with international harmonized guidelines for nonclinical safety studies (FDA, EMA, MHRA, PMDA)
Industry-first full algorithm transparency via GitHub - our advantage is quantum speed, not algorithm secrecy
Complete user control over analysis data - export directly to your repositories with zero vendor lock-in
Our quantum computing infrastructure operates at the L1 Lagrange point, providing unique advantages for both computational stability and Earth observation:
MosaeQ targets a multi-billion-dollar opportunity across three key markets:
Our target customers include pharmaceutical AI companies, food manufacturers, and organizations requiring industrial certifications and HERA support for biosecurity applications.
MosaeQ is engaged with leading organizations in quantum computing, environmental monitoring, and space technology:
Free access to public health data with early sign-ups for premium features
Additional Revenue: Biopharmaceutical IP for personalized 3D-print immunization streams (EMA-FDA combinatoric excipient pathway)
Dedicated License: €799.99/month
Enterprise License + cisLunar Real Estate: €3,799.99/month
Target customers: Pharma AI, Food AI manufacturers requiring industrial certifications and HERA support
Early Momentum & Validation
MosaeQ has demonstrated strong early traction with projected Year 1 to Year 2 revenue growth exceeding 1,350%
€1.13M
Year 1 Revenue (Projected)
€16.52M
Year 2 Revenue (Projected)
€66.38M
Year 3 Revenue (Projected)
Total Startup Costs
€835,000
Top Startup Cost
€250,000
Advanced Quantum Computing Hardware
Year 1 Total Revenue (Projected)
€1.13M
(specifically, €1,133,208.86)
Total Financing Income
€11.15M
CEO, Founder & Inventor
F. Hanna Campbell is the visionary founder of Mosae Zorg Industries (MosaeQ), pioneering quantum-enhanced predictive computing for biodefense and materials science.
Email: fhcampbell@mosaezorg.com
Phone: +49(0)3040817284 (International)
Website: mosaeq.com / mosaezorg.com
Wir verwenden Cookies und ähnliche Technologien, um die Funktionalität unserer Website zu gewährleisten und Ihr Nutzererlebnis zu verbessern. Einige Cookies sind technisch notwendig, während andere uns helfen, unsere Dienste zu optimieren.
Gemäß der DSGVO benötigen wir Ihre ausdrückliche Zustimmung für die Verwendung von nicht-notwendigen Cookies. Sie können Ihre Einstellungen jederzeit ändern.
Sie haben das Recht auf Auskunft, Berichtigung, Löschung und Einschränkung der Verarbeitung Ihrer personenbezogenen Daten. Weitere Informationen finden Sie in unserer Datenschutzerklärung und im Impressum.